4 anesthesia drugs with the biggest unit price hikes

Written by Angie Stewart | January 29, 2019 | Print  |

Hospitals' outpatient drug expenditure per admission grew 28.7 percent between 2015 and 2017, according to a study commissioned by the American Hospital Association, Federation of American Hospitals and American Society of Health-System Pharmacists.

Anesthesia Business Consultants President and CEO Tony Mira reviewed the results and shared takeaways for anesthesiologists and nurse anesthetists. These are the four drugs with the highest unit price increases (among drugs with total spending of more than $1 million in 2017):

1. Hydromorphone: 107 percent
2. Succinylcholine: 54 percent
3. Brevibloc: 53 percent
4. Dextrose: 52 percent

"The AHA and the ASA have submitted legislative, regulatory and best practice recommendations to the FDA to address drug shortages and drug pricing," Mr. Mira said.

More articles on anesthesia:
Spencer Hospital reopens surgery center after fire — 3 insights
10 ASCs focused on GI & endoscopy
Buying refurbished medical equipment? Ask these 5 Qs first

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.